跳至主要内容
临床试验/EUCTR2016-002595-27-NL
EUCTR2016-002595-27-NL进行中(未招募)1 期

Cytoreductive surgery and Intraperitoneal chemotherapy and for Stomach CAncer: a feasibility study - CISCA

niversity Medical Center Utrecht0 个研究点目标入组 20 人开始时间: 2017年3月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -Histologically proven adenocarcinoma of the stomach.
  • -Surgical resectable carcinoma (T1-4a, N1-3) (table 1)
  • -Clinical or pathological proven peritoneal metastases
  • -Peritoneal Cancer Index (PCI) =12
  • -European Clinical Oncology Group (ECOG) performance status 0,1 or 2
  • -Age = 18
  • -Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Distant metastases other than peritoneal metastases
  • - Siewert type I gastro-esophageal junction tumor.
  • - Peritoneal carcinomatosis as a presentation of recurrent disease
  • - Pregnancy
  • - Contraindication to cisplatin (e.g. hypersensitivity, HIV infection and inadequate bone marrow, hepatic or renal function)

研究者

相似试验